AMPHOTERICIN-B VERSUS FLUCONAZOLEAS EMPIRIC THERAPY FOR REFRACTORY FEVER IN CANCERVISCOLI et al, EUR.J.CANCER 1996

AMPHOTERICIN-B

FLUCONAZOLE

SURVIVAL

DEATH DUE TO

FUNGAL INFECTION

ADVERSE EVENTS

66%

0%

82%

75%

0%

32%

0.8 mg/kg/48 hrs

n = 56

400 mg/24 hrs

n = 56

Previous slide

Next slide

Back to first slide

View graphic version